Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sitehop develops cutting-edge networking and cyber-security solutions.
Inephany is a company focusing on improving the efficiency of AI, particularly neural networks and Large Language Models (LLMs).
Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.
Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.
Pimloc's deep learning SaaS platform, Secure Redact, enables public and private organisations to protect personal data in video at scale.
Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
At Constructive Bio we rewrite genomes to build the biomolecules of the future.
Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
iPronics has pioneered the field of software-defined photonics and introduces the world's first optical circuit switch.
Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.
RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI.
PhoreMost is a new-model drug discovery company based in Cambridge, UK.
Riverlane develops software solutions to harness the power of quantum computers for practical applications.
creating quantum computers atom by atom
Embedded AI threat management for critical industrial and defence embedded technologies.
Machine learning for automotive innovators
Pressure Sensitive Multi-Touch for Next-Generation Smart Devices including Smartphones, Tablets, Automotive and Industrial
An AI and machine learning deployment, management and observability platform.
Unlikely AI is a talented group that is approaching artificial intelligence from a daring, fresh angle.
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
Brytlyt provides transformational serverless acceleration for analytics
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
Charco Neurotech is a medical technology company that develops non-invasive wearable devices.
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Amadeus Capital Partners has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Amadeus Capital Partners's top investment sectors include Software, Biotechnology, Artificial Intelligence (AI), Machine Learning, Information Technology. The firm invests across 44 different industry categories.
Among tracked funding rounds, Ori Biotech received $100.0M in a Series B round. Amadeus Capital Partners's total known invested capital is $1.6B.
Amadeus Capital Partners's average investment size is $25.9M across its portfolio of 79 companies.
Recent Amadeus Capital Partners portfolio additions include Sitehop, Inephany, Xampla, Paragraf, Pimloc. These companies were founded in 2020 or later.